10X Genomics Inc Cash Flow Reinvestment Rate
10X Genomics Inc cash flow reinvestment rate. 10X Genomics Inc (TXG) has a Cash Flow Reinvestment Rate of 0.12x as of June 2026, reinvesting $2.04 Million (capex $1.59 Million plus investments $454.00K) from operating cash flow of $16.97 Million. See TXG financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of 10X Genomics Inc (2019–2025)
Cash flow reinvestment rate of 10X Genomics Inc from 2019 to 2025. Historical reinvestment intensity for 10X Genomics Inc across 3 annual periods. Explore how well can 10X Genomics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
10X Genomics Inc Cash Flow Reinvestment Rate by Year (2019–2025)
10X Genomics Inc cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for 10X Genomics Inc. For the full cash flow conversion analysis, see 10X Genomics Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | $7.70 Million | $136.05 Million | $5.93 Million | ▼ -99.2% |
| 2024 | 6.76x | $45.02 Million | $6.66 Million | $12.39 Million | ▲ +173.5% |
| 2019 | 2.47x | $85.53 Million | $34.63 Million | $42.77 Million | — |